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ABSTRACT Light scattering technique has been used to study the interaction between ﬁbroblast growth factor (FGF) and its
receptor. In this study, a general mathematical model has been developed where the concentration of product formed by the
interaction of two proteins and its dependence on the initial concentration of interacting proteins have been determined using laser
light scattering. Calculated hydrodynamic diameters reveal that both human ﬁbroblast growth factor (hFGF-1) and its receptor
domain (D2 domain) exist as monomers in solution. Titration of hFGF-1 and the D2 domain of FGFR show that they interact in a 1:1
stoichiometry in solution. The binding stoichiometry does not depend on the concentrations of the interacting proteins. The results of
this study, for the ﬁrst time to our knowledge, provide an unambiguous evidence that the 2:2 binary complex of FGF and FGFR
observed in the crystal structures of the FGF-FGFR complex (in the absence of heparin) is possibly a crystallization artifact.
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Fibroblast growth factors (FGFs) are a family of growth
factors that participate in key cellular processes such as cell
proliferation, cell differentiation, wound healing, and tumor
growth (1). FGFs exert their biological activity by binding to
their cell surface tyrosine kinase receptors (FGFRs). FGFRs
contain an extracellular domain, a short transmembrane, and a
cytoplasmic tyrosine kinase domain. The extracellular domain
consists of three structural subdomains called D1, D2, and D3.
Mutational studies have shown that the D2 subdomain con-
tributes to the ligand (FGF) binding (2). X-ray crystallo-
graphic studies consistently show that the FGF-receptor
complex is a symmetric dimer both in the absence and the
presence of heparin (2,3). The stoichiometry of interaction
between FGF and FGFR (in the absence of heparin), derived
from the crystal structures, has recently come under intense
scrutiny. Previous studies based on size-exclusion chroma-
tography (SEC) have consistently revealed the formation of a
1:1 complex of FGF and FGFR (4). However, the debate on
the stoichiometry remains largely unresolved owing to the
resolution of the SEC technique, and the problems of stability
of the FGF-FGFR complex under the conditions used in the
SEC experiments. Therefore, there is an increasing need to
develop new approaches to reliably resolve the existing con-
troversy on the stoichiometry of the FGF-FGFR complex.
Light-scattering techniques are versatile optical methods for
characterizing physico-chemical properties of macromolecu-
lar solutions (5). They can provide information about the size,
diffusion coefficient, conformation, and aggregation of bio-
molecules. Although the sensitivity of dynamic light scatter-
ing (DLS) technique usually precludes the determination of
affinities and association or dissociation rate constants, we
show that DLS can be quite useful in characterizing the stoi-
chiometry of protein complexes at high concentrations in solu-
tion. In many cases, biochemical methods provide information
about the interaction of protein A with another protein B, but
the stoichiometry of this interaction is often elusive. In this
study, we describe a new mathematical model that can help in
the determination of the stoichiometry, binding constant, and
the concentration of protein-protein complexes formed in a
pool of two freely interacting protein partners. We have used
our model to examine the binding stoichiometry and binding
affinity between FGF and its receptor.
Bovine pancreatic ribonuclease (RNase A) was obtained
from Sigma Aldrich (St. Louis, MO). All other reagents used
were of the highest purity available. Cloning, overexpression,
and purification of the D2 domain of FGFR2 and human
fibroblast growth factor (hFGF-1) have been reported previ-
ously (1,6). All light scattering measurements were performed
using Brookhaven Instruments (Holtsville, NY) BI-200SM
goniometer and BI-9000AT digital autocorrelator. Solutions
were prepared and were filtered (0.2 mm) to remove dust. All
of the measurements were carried out at 25C. The light
source was a He-Ne ion laser (Spectra Physics Lasers,
Mountain View, CA; l ¼ 632.8 nm). A photomultiplier tube
mounted on the goniometer-collected photons scattered by the
sample at an angle of 90. Static light scattering intensity is
related to the molecular mass of the protein, its concentration,
scattering angle, and the wavelength, which in principle are
known. Dynamic light scattering measurements utilize the
temporal correlations of the scattering intensity fluctuations,
which are related to the Brownian motion of the solute. For
dilute solutions, the diffusion coefficient Di is related to the
hydrodynamic diameter di of the scatterers and the solvent
viscosity h through the Stokes-Einstein relation
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Di ¼ kBT=3pndi; (1)
where kB is the Boltzmann constant. The nonnegative least-
squares algorithm was used in the Laplace inversion of the
autocorrelation function to obtain the size distribution.
Dynamic light scattering and static light scattering studies
revealed the diffusion coefficient, diameter, and molecular
mass of hFGF-1 to be 1.173 3 106 cm2/s, 3.8 nm, and ;16
kDa, respectively (see Supplementary Material, Table S1).
Both RNase A and D2 domain have nearly the same diffusion
coefficient, diameter, and molecular mass of ;1.278 3 106
cm2/s, 3.5 nm, and ;13.7 kDa, respectively (Table S1).
Dynamic light scattering experiments show that a homodimer
is not formed and all the three proteins remain as monomers in
the concentration range of 10–650 mM (Fig. S1).
Model for calculating concentration of product
formed by the interaction of two proteins
Since all species contribute to scattering, correlation time (G)
for the scattered-intensity-measure weighed diffusion con-












where ci, mi, and Di are, respectively, the molar concentration,
molecular mass, and diffusion coefficient of protein i. Using
the Einstein-Stokes relation, we find that effective diameter








where x, y denote the initial concentrations of the interacting
proteins, and z that of the product complex. With the help of
this formula, we can extract the value of z, the concentration of
the protein complex, from the measured deff because all
the other parameters are either known or can be calculated
using the standard diameter versus molecular mass relation
di ¼ 1:235M0:404i where di is the diameter and Mi is the mo-
lecular mass in kiloDaltons. Effective diameter and molecular
mass values of two proteins, hFGF-1 (effective diameter 3.8
nm and molecular mass 16 kDa) and RNase A as well as D2
domain (effective diameter 3.5 nm and molecular mass 13.7
kDa) obtained by dynamic light scattering, fit well to the
standard curve (Fig. S2).
When two proteins interact, the effective diameter will de-
pend on the concentration, molar mass, and effective diameter
of each of the proteins as well as those of the product formed
by the interacting proteins. The change in hydrodynamic
diameter was measured by titrating a fixed concentration of
hFGF-1 (100 mM) with increasing concentrations of the D2
domain (in the concentration range of 50–600 mM; Fig. 1).
The diameter steeply increases from 3.8 nm to 4.1 nm until
the concentration of the D2 domain reaches 100 mM (Fig. 1).
Increase in the D2 domain concentration beyond 100 mM
does not result in a significant change in the hydrodynamic
diameter. Control experiments involving the titration of 100
mM hFGF-1 with RNase A, which is not known to interact
with hFGF-1, caused a marginal decrease in the hydrodynamic
diameter (Fig. 1). Similarly, the maximum hydrodynamic
diameter value attained, upon varying the concentrations (in
the range of 50–750 mM) of both hFGF-1 and the D2 domain,
is 5.1 nM (Fig. 2 A).
Hydrodynamic diameter 5.1 nm, when extrapolated to the
standard plot (of molecular mass versus hydrodynamic diam-
eter), corresponds to a molecular mass of ;31 kDa; this is
approximately equal to combined molecular mass of hFGF-1
and the D2 domain. These results are consistent with 1:1 stoi-
chiometry of binding between hFGF-1 and the D2 domain.
Control experiments involving the variation in the concentra-
FIGURE 1 Dynamic light scattering of hFGF-1 (100 mM), in the
presence of increasing concentrations (50–600 mM) of the D2
domain of FGFR (solid circles), and RNase A (open circles).
Experiment was performed at 25C in 10 mM phosphate buffer
(pH 6.5) containing 50 mM NaCl.
FIGURE 2 Dynamic light scattering obtained upon mixing in-
creasing concentrations of hFGF-1 in equimolar ratio (1:1) with
increasing concentrations of the D2 domain of FGFR (solid
circles), and increasing concentrations of RNase A (open circles)
(A). The range of hFGF-1 concentration used is 25–750 mM. (B)
Concentration of the hFGF-1-D2 domain binary complex (z) formed
when a ﬁxed concentration of hFGF-1 (100 mM) was titrated with
increasing concentrations of the D2 domain. Experiment was
performed at 25C in 10 mM phosphate buffer (pH 6.5)
containing 50 mM NaCl.
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tion of both hFGF-1 and RNase A (in the range of 50–750mM)
caused no change in the hydrodynamic diameter (Fig. 2 A).
The mathematical model developed in this study allows
the calculation of the concentration of the products of
interaction (z) based on the observed hydrodynamic diam-
eter. Logically, if the stoichiometry of interaction is 1:1, the
value of z is expected to show a linear increase when a fixed
concentration (100 mM) of hFGF-1 is titrated with increasing
concentrations of the D2 domain. Results presented in Fig. 2
B reveal a linear increase in the z-value until the concentra-
tion of the receptor domain reached 100 mM. The z-values
are observed to reach a plateau when the concentration of the
D2 domain is raised beyond 600 mM. The observed plateau
is primarily due to the limiting concentration (100 mM) of
hFGF-1. These results confirm that hFGF-1 and the D2
domain of FGFR form a 1:1 binary complex in solution. It
should be of interest to note that the conclusions drawn from
our DLS data are consistent with the biophysical studies
reported by Harmer et al. (4).
The binding affinity (Kd) between the interacting proteins
can be readily determined based on the calculated z-value. The
binding constant (Kd) characterizing the interaction between
hFGF-1 and its receptor domain is calculated to be 328 mM.
Isothermal titration calorimetry experiments were performed
to examine the reliability of the Kd value calculated from the
dynamic light scattering experiments. Isothermal titration cal-
orimetry is a useful technique to measure the binding affinity
and stoichiometry of protein-protein or protein-ligand inter-
actions. The binding isotherm representing the binding be-
tween hFGF-1 and the receptor domain is hyperbolic and
proceeds with the evolution of heat. Least-square fitting of the
raw isotherm shows the hFGF-1, and the D2 domain interact
in a 1:1 stoichiometry (Fig. S3). The Kd value obtained from
the isothermal titration calorimetry data is in the same range
(;184 mM) as that calculated from the DLS experiments.
The binding stoichiometry obtained from the DLS exper-
iments is in marked contrast to the 2:2 complex observed in
the crystal structures of the FGF-FGFR complex. Crystal struc-
tures of the FGF-FGFR complex (in the absence of heparin)
reveal that the interactions between residues in the D2 domain
of FGFR solely constitute the dimer interface. The results of
this study clearly demonstrate that D2 domain exists as a
monomer in both its free and FGF-bound forms. Crystal struc-
ture of the receptor domain alone is not available, but we
believe that the 2:2 binary complex of FGF and FGFR (in the
absence of heparin) observed in the crystal structures is pos-
sibly a crystallization artifact. The disparity observed between
our DLS results and the crystal structure data can possibly be
attributed to experimental conditions used in the crystalliza-
tion process. Crystals of the FGF-receptor complex were
grown in reservoir buffers containing high salt (1.6 M
ammonium sulfate) plus just 20% glycerol (2), or mixture of
9% sucrose 1 2% glucose 1 8% glycerol 1 8% ethylene
glycol (3). High sulfate concentrations (used in the crystal-
lization process) may facilitate the 2:2 dimer formation by
promoting intermolecular interactions either through salt-
bridging or by screening the repulsive forces that operate
between the positively charged residues in the D2 domain.
Crystal structure of FGF-receptor complex reveals the pres-
ence of a positively charged canyon contributed by residues in
the D2 domain (2). In addition, the excluded volume effects of
the crowding agents used in the crystallization process may
also play a significant role in the dimerization of the recep-
tor. In fact, crowding agent used in the crystallization of
G-quadruplex was shown to drive a conformational change
(7). It appears that FGF initially interacts with its receptor in a
1:1 stoichiometry, and the dimerization of the receptor, and
subsequent autophosphorylation of the cytoplasmic tyrosine
kinase domains is triggered only after FGF-FGFR complex is
stabilized by binding to the cell surface glycosoamino
glycans. We believe that this study will help clear the existing
controversy on the structural events involved in FGF signal-
ing. In addition, the mathematical model developed in this
study will be generally applicable to calculate the binding
stoichiometry and determine the relative concentrations of
protein-protein complexes using dynamic light scattering.
SUPPLEMENTARY MATERIAL
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